Publicaciones (69) Publicaciones en las que ha participado algún/a investigador/a

2022

  1. A Brucella melitensis H38ΔwbkF rough mutant protects against Brucella ovis in rams

    Veterinary research, Vol. 53, Núm. 1, pp. 16

  2. A predictive model for hospitalization and survival to COVID-19 in a retrospective population-based study

    Scientific Reports, Vol. 12, Núm. 1

  3. A systematic literature review and expert consensus on risk factors associated to infection progression in adult patients with respiratory tract or rectal colonisation by carbapenem-resistant Gram-negative bacteria

    Revista Espanola de Quimioterapia, Vol. 35, Núm. 5, pp. 455-467

  4. Acoustic surveillance of cough for detecting respiratory disease using artificial intelligence

    ERJ Open Research, Vol. 8, Núm. 2

  5. An Experimental Murine Model to Assess Biofilm Persistence on Commercial Breast Implant Surfaces

    Microorganisms, Vol. 10, Núm. 10

  6. Antibody Response in Immunocompromised Patients After the Administration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine BNT162b2 or mRNA-1273: A Randomized Controlled Trial

    Clinical Infectious Diseases, Vol. 75, Núm. 1, pp. E585-E593

  7. Characterization of Human Papillomavirus 16 from Kinshasa (Democratic Republic of the Congo)—Implications for Pathogenicity and Vaccine Effectiveness

    Microorganisms, Vol. 10, Núm. 12

  8. Clonal Complexes 23, 10, 131 and 38 as Genetic Markers of the Environmental Spread of Extended-Spectrum β-Lactamase (ESBL)-Producing E. coli

    Antibiotics, Vol. 11, Núm. 11

  9. Correction to: A rapid and low‑cost protocol for the detection of B.1.1.7 lineage of SARS‑CoV‑2 by using SYBR Green‑based RT‑qPCR (Molecular Biology Reports, (2021), 48, 11, (7243-7249), 10.1007/s11033-021-06717-y)

    Molecular Biology Reports

  10. Depletion of Conventional Type-1 Dendritic Cells in Established Tumors Suppresses Immunotherapy Efficacy

    Cancer research, Vol. 82, Núm. 23, pp. 4373-4385

  11. Detection of azole resistance in Aspergillus fumigatus complex isolates using MALDI-TOF mass spectrometry

    Clinical Microbiology and Infection, Vol. 28, Núm. 2, pp. 260-266

  12. Development of a Bacterial Nanoparticle Vaccine Against Escherichia coli

    Methods in Molecular Biology (Humana Press Inc.), pp. 357-365

  13. Diagnosis of COVID-19. What have we learned after two years of the pandemic?

    Advances in Laboratory Medicine, Vol. 3, Núm. 2, pp. 97-99

  14. Diagnóstico de COVID-19 ¿qué hemos aprendido tras dos años de pandemia?

    Advances in Laboratory Medicine, Vol. 3, Núm. 2, pp. 100-102

  15. Dysautonomia in COVID-19 Patients: A Narrative Review on Clinical Course, Diagnostic and Therapeutic Strategies

    Frontiers in Neurology, Vol. 13

  16. Effect of Combination Antibiotic Empirical Therapy on Mortality in Neutropenic Cancer Patients with Pseudomonas aeruginosa Pneumonia

    Microorganisms, Vol. 10, Núm. 4

  17. Effectiveness of Antiviral Therapy in Highly-Transmissible Variants of SARS-CoV-2: A Modeling and Simulation Study

    Frontiers in Pharmacology, Vol. 13

  18. Estudio de la actividad bactericida de péptidos antimicrobianos producidos por bacterias ácidolácticas aisladas de animales salvajes

    Microbiología de los alimentos bajo el concepto de One Health: libro de comunicaciones

  19. Exploiting 4-1BB immune checkpoint to enhance the efficacy of oncolytic virotherapy for diffuse intrinsic pontine gliomas

    JCI Insight, Vol. 7, Núm. 7

  20. Galectin-3 inhibition boosts the therapeutic efficacy of Semliki Forest virus in pediatric osteosarcoma

    Molecular Therapy - Oncolytics, Vol. 26, pp. 246-264